News > Cervical cancer vaccine to be rolled out next year for girls aged 9-14 yrs

Cervical cancer vaccine to be rolled out next year for girls aged 9-14 yrs

With the cheaper, indigenously developed HPV (human papillomavirus) vaccine to prevent cervical cancer scheduled to become available by April-May next year, a nationwide immunisation drive for girls in the age group of 9-14 years is likely to begin by mid-2023. The quadrivalent vaccine called Cervavac, developed by the Serum Institute of India (SII), offers protection against four strains of HPV — 16, 18, 6, and 11.